Cargando...

Proteomic cancer biomarkers from discovery to approval: it’s worth the effort

The current landscape of cancer biomarkers is changing rapidly, with new and exciting developments. With the advances of proteomic technologies, many potential cancer biomarkers have been discovered. However, the number of new cancer biomarkers cleared or approved by the US FDA is rather limited. Al...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Li, Danni, Chan, Daniel W
Formato: Artigo
Idioma:Inglês
Publicado: 2014
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4079106/
https://ncbi.nlm.nih.gov/pubmed/24646122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14789450.2014.897614
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!